Resources
Explore how healthcare organizations, researchers, and life sciences partners from our global community use TriNetX to turn real-world patient data into evidence that drives progress.
As 2025 wraps up, the TriNetX team is reflecting on a year of milestones, among them, being named to The Healthcare Technology Report’s Top 50 Healthcare Technology Companies list this November.
Chimeric antigen receptor (CAR) T-cell therapy is among the most promising breakthroughs in modern oncology. By genetically engineering a patient’s T lymphocytes to recognize and destroy cancer cells, CAR T-cell therapy has redefined what is possible in adoptive cellular immunotherapy.
To succeed, biotechs are rethinking how clinical research gets done. RWD, AI, and patient-centric strategies are no longer experimental; they’re emerging as the core toolkit for companies determined to accelerate progress while controlling risk.
The recent ISPOR Europe 2025 conference, held under the inspiring theme ‘Powering Value and Access Through Patient-Centered Collaboration
Real-world data (RWD) plays a crucial role in clinical research and decision-making, yet navigating its complexity remains a significant challenge. RWD typically comes from claims—open or closed—or from electronic health records (EHRs).
I recently had the opportunity to sit down with Danny Levine for an episode of his RARECast podcast to discuss something I’m deeply passionate about: how real-world data (RWD) is transforming the landscape of rare disease research.
At the recent SCOPE Europe conference, I spoke about a fundamental shift redefining the future of clinical research.
When we think about the future of clinical research, it’s easy to picture gleaming technology, seamless data flows, and a world where trials are faster, smarter, and more inclusive. But let’s be honest. We’re not there yet.
We’re proud to announce that our TriNetX LIVE™ platform was recognized as a Best of Show Finalist at the SCOPE Europe conference.
With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces competitors and fuels high-impact science published in top medical journals.
Clinical research is at a crossroads. The technology exists, the data is available, and the ambition is clear, but adoption of truly integrating Artificial Intelligence (AI) and data-driven trials often stalls due to risk, trust, and organizational inertia
Discover why TriNetX is the most-cited EHR dataset in peer-reviewed publications. Explore how our high-quality real-world data (RWD) powers high-impact research in top-tier medical journals and drives global breakthroughs in real-world evidence.
Join a global community of innovators. Discover how to turn real-world data into groundbreaking clinical insights.
Meet TriNetX at Events
Bridge the gap between raw data and patient care. Meet the team at flagship healthcare conferences across the globe, and learn how to leverage the TriNetX ecosystem to streamline trial timelines, improve site collaboration, and publish research that changes lives.
